SciELO - Scientific Electronic Library Online

 
vol.97The Balmis expedition in the Supplement to the Gazeta de Madrid (October 14, 1806), Hispanic diffusionMonkeypox and men who have sex with men: we need to treat it with a destigmatizing perspective author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Española de Salud Pública

On-line version ISSN 2173-9110Print version ISSN 1135-5727

Abstract

MARTIN-RIOBOO, Enrique et al. Lights and shadows of the 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Rev. Esp. Salud Publica [online]. 2023, vol.97, e202308064.  Epub Dec 06, 2024. ISSN 2173-9110.

General practitioners see in their consultation a a significant number of patients at high vascular risk (VR). The European Guidelines for Cardiovascular Disease Prevention (2021) recommend a new risk classification and intervention strategies on on vascular risk factors (RF), with the aim of providing a shared decision-making recommendations between professionals and patients. In this document we present a critical analysis of these guidelines, offering possible solutions that can be implemented in Primary Care.

It should be noted that there are positive aspects (lights) such as that the SCORE2 (from forty to sixty-nine years) and SCORE2-OP models (from seventy to eighty-nine years) are based on more current cohorts and measure cardiovascular risk in a more accurately manner. In addition, it is proposed to differentiate different risk thresholds according to age-groups. For sake of practicality, cardiovascular risk can be estimated using different websites with the new computer models. However, among the negative aspects (shadows), it seems to be add complexity implementing nine subgroups of subjects according to their age or level of risk, with a defined thresholds that could cause a substantial increase in the potential number of subjects susceptible to treatment without a clear evidence that supports it. In addition, two-step RF interventions could delay achievement of therapeutic goals, especially in very high-risk patients, diabetics, or patients with cardiovascular disease.

Given these limitations, in this document we propose practical recommendations in order to simplify and facilitate the implementation of the guideline in primary care.

Keywords : Vascular disease; Vascular risk factors; Vascular risk; Risk scales; Risk prediction; Residual risk; Clinical practice guidelines; Competitive risk.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )